Brean Murray Carret & Co. Maintains a 'Buy' on Dendreon (DNDN); MEDCAC Panel Docs Relatively Benign

Go back to Brean Murray Carret & Co. Maintains a 'Buy' on Dendreon (DNDN); MEDCAC Panel Docs Relatively Benign